logo
logo

Inbrain Neuroelectronics Secures $17 Million In Series A Funding For First Ai-Powered Graphene-Brain Interface

Mar 30, 2021•over 4 years ago

Amount Raised

$17 Million

Round Type

series a

Barcelona

Description

INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent graphene-brain interface, today announced $16.8 million in Series A funding for its disruptive system for treating epilepsy and Parkinson’s disease.

Company Information

Company

Inbrain Neuroelectronics

Location

Barcelona, Catalonia, Spain

About

INBRAIN Neuroelectronics S.L., founded in 2019, is a medical device company dedicated to developing the world’s first intelligent graphene-brain interface to treat a variety of conditions. INBRAIN’s first product is designed to read and modulate brain activity, using artificial intelligence to trigger adaptive responses for personalized neurological therapy for epilepsy and Parkinson’s disease. For more information, please visit www.inbrain-neuroelectronics.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech